Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keramod Gel vs Aldara Cream in Actinic Keratosis
2024-515667-60-00Phase 2Authorised
- Sponsor
- Ojer Pharma
- Start
- Sep 2024
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in actinic keratosis (AK) comparing Keramod gel with Aldara cream (2 arms). Planned start Sep 2024; status: authorised.
02
Drugs
Keramodimiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2024-515667-60-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515667-60-00.